0001209191-22-057333.txt : 20221116
0001209191-22-057333.hdr.sgml : 20221116
20221116170634
ACCESSION NUMBER: 0001209191-22-057333
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20221116
FILED AS OF DATE: 20221116
DATE AS OF CHANGE: 20221116
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Bitterman Robert J
CENTRAL INDEX KEY: 0001304395
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36304
FILM NUMBER: 221396020
MAIL ADDRESS:
STREET 1: C/O RXI PHARMACEUTICALS CORPORATION
STREET 2: 1500 WEST PARK DRIVE, SUITE 210
CITY: WESTBOROUGH
STATE: MA
ZIP: 01581
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Phio Pharmaceuticals Corp.
CENTRAL INDEX KEY: 0001533040
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 257 SIMARANO DRIVE
STREET 2: SUITE 101
CITY: MARLBOROUGH
STATE: MA
ZIP: 01752
BUSINESS PHONE: (508) 767-3861
MAIL ADDRESS:
STREET 1: 257 SIMARANO DRIVE
STREET 2: SUITE 101
CITY: MARLBOROUGH
STATE: MA
ZIP: 01752
FORMER COMPANY:
FORMER CONFORMED NAME: RXi Pharmaceuticals Corp
DATE OF NAME CHANGE: 20111019
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-11-16
0
0001533040
Phio Pharmaceuticals Corp.
PHIO
0001304395
Bitterman Robert J
C/O PHIO PHARMACEUTICALS CORP.
257 SIMARANO DRIVE, SUITE 101
MARLBOROUGH
MA
01752
1
1
0
0
Interim Executive Chairman
Series D Preferred Stock, $0.0001 par value
2022-11-16
4
P
0
1
1750.00
A
1
D
The outstanding share of Series D Preferred Stock shall be redeemed in whole, but not in part, at any time: (i) if such redemption is approved by the Board of Directors in its sole discretion or (ii) automatically and effective upon the approval of an amendment to the Certificate of Incorporation to implement a reverse stock split. Upon redemption, the share of Series D Preferred Stock will receive consideration of $1,750.00 in cash.
Caitlin Kontulis, attorney-in-fact
2022-11-16